在治疗儿童急性淋巴细胞白血病时，初始治疗应将天然大肠杆菌天冬酰胺酶替换为聚乙二醇化天冬酰胺酶。 - Suppr

Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia.

作者信息

Tong Wing H, Mesegué Montserrat, Dapena José Luís, Camós Mireia, Rives Susana

机构信息

Department of Public Health and Primary Care (PHEG), Leiden University Medical Center, Leiden, The Netherlands.

Argos Zorggroep "DrieMaasStede", Center for Specialized Geriatric Care, Schiedam, The Netherlands.

出版信息

Hematol Oncol. 2022 Oct;40(4):809-811. doi: 10.1002/hon.2960. Epub 2022 Jan 2.

DOI:10.1002/hon.2960

PMID:34961954

Abstract

摘要

相似文献

Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia.

Hematol Oncol. 2022 Oct;40(4):809-811. doi: 10.1002/hon.2960. Epub 2022 Jan 2.

A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.

Blood. 2014 Mar 27;123(13):2026-33. doi: 10.1182/blood-2013-10-534347. Epub 2014 Jan 21.

Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy.

Haematologica. 2013 May;98(5):753-9. doi: 10.3324/haematol.2012.073510. Epub 2013 Feb 12.

The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia.

Haematologica. 2014 Nov;99(11):1716-21. doi: 10.3324/haematol.2014.109413. Epub 2014 Aug 22.

Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group.

Eur J Cancer. 2022 Feb;162:65-75. doi: 10.1016/j.ejca.2021.11.016. Epub 2021 Dec 23.

Lower incidence of clinical allergy with PEG-asparaginase upfront versus the sequential use of native E. coli asparaginase followed by PEG-ASP in pediatric patients with acute lymphoblastic leukemia.

Hematol Oncol. 2021 Dec;39(5):687-696. doi: 10.1002/hon.2914. Epub 2021 Aug 16.

Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.

Pediatr Blood Cancer. 2010 Feb;54(2):199-205. doi: 10.1002/pbc.22225.

Individualized Asparaginase Dosing in Childhood Acute Lymphoblastic Leukemia.

J Clin Oncol. 2020 Mar 1;38(7):715-724. doi: 10.1200/JCO.19.02292. Epub 2020 Jan 10.

How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia.

Blood. 2020 Mar 26;135(13):987-995. doi: 10.1182/blood.2019002477.

Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia.

Pediatr Blood Cancer. 2016 Feb;63(2):228-33. doi: 10.1002/pbc.25757. Epub 2015 Sep 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia.

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia.

作者信息

机构信息

出版信息

相似文献